Back to Report Store Home

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Published: Jun-2018
  • Report Code: GBIHC037IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Type1 diabetes (Juvenile Diabetes)

Table 2: Number of Products under Development by Companies, Type1 diabetes (Juvenile Diabetes)

Table 3: Number of Products under Development by Universities/Institutes, Type1 diabetes (Juvenile Diabetes)

Table 4: Products under Development by Companies, Type1 diabetes (Juvenile Diabetes)

Table 5: Products under Development by Universities/Institutes, Type1 diabetes (Juvenile Diabetes)

Table 6: Number of Products under Development for Type2 diabetes

Table 7: Number of Products under Development by Companies, Type2 diabetes

Table 8: Number of Products under Development by Universities/Institutes, Type2 diabetes

Table 9: Products under Development by Companies, Type2 diabetes

Table 10: Products under Development by Universities/Institutes, Type2 diabetes

Table 11: Number of Products under Development for Hyperinsulinemia

Table 12: Number of Products under Development by Companies, Hyperinsulinemia

Table 13: Number of Products under Development by Universities/Institutes, Hyperinsulinemia

Table 14: Products under Development by Companies, Hyperinsulinemia

Table 15: Products under Development by Universities/Institutes, Hyperinsulinemia

Table 16: Number of Products under Development for Hyperglycemia

Table 17: Number of Products under Development by Companies, Hyperglycemia

Table 18: Number of Products under Development by Universities/Institutes, Hyperglycemia

Table 19: Products under Development by Companies, Hyperglycemia

Table 20: Products under Development by Universities/Institutes, Hyperglycemia

Table 21: Number of Products by Stage and Target, Type1 diabetes (Juvenile Diabetes)

Table 22: Number of Products by Stage and Mechanism of Action, Type1 diabetes (Juvenile Diabetes)

Table 23: Number of Products by Stage and Route of Administration, Type1 diabetes (Juvenile Diabetes)

Table 24: Number of Products by Stage and Molecule Type, Type1 diabetes (Juvenile Diabetes)

Table 25: Number of Products by Stage and Target, Type2 diabetes

Table 26: Number of Products by Stage and Mechanism of Action, Type2 diabetes

Table 27: Number of Products by Stage and Route of Administration, Type2 diabetes

Table 28: Number of Products by Stage and Molecule Type, Type2 diabetes

Table 29: Number of Products by Stage and Target, Hyperinsulinemia

Table 30: Number of Products by Stage and Mechanism of Action, Hyperinsulinemia

Table 31: Number of Products by Stage and Route of Administration, Hyperinsulinemia

Table 32: Number of Products by Stage and Molecule Type, Hyperinsulinemia

Table 33: Number of Products by Stage and Target, Hyperglycemia

Table 34: Number of Products by Stage and Mechanism of Action, Hyperglycemia

Table 35: Number of Products by Stage and Route of Administration, Hyperglycemia

Table 36: Number of Products by Stage and Molecule Type, Hyperglycemia

Table 37: Type1 diabetes (Juvenile Diabetes) – Pipeline by Adocia SAS,

Table 38: Type1 diabetes (Juvenile Diabetes) – Pipeline by AiCuris GmbH & Co KG,

Table 39: Type1 diabetes (Juvenile Diabetes) – Pipeline by Allist Shanghai Pharmaceutical Technology Co Ltd,

Table 40: Type1 diabetes (Juvenile Diabetes) – Pipeline by Amarantus Bioscience Holdings Inc,

Table 41: Type1 diabetes (Juvenile Diabetes) – Pipeline by Amarna Therapeutics BV,

Table 42: Type1 diabetes (Juvenile Diabetes) – Pipeline by apceth Biopharma GmbH,

Table 43: Type1 diabetes (Juvenile Diabetes) – Pipeline by Aphios Corp,

Table 44: Type1 diabetes (Juvenile Diabetes) – Pipeline by Apodemus AB,

Table 45: Type1 diabetes (Juvenile Diabetes) – Pipeline by Arecor Ltd,

Table 46: Type1 diabetes (Juvenile Diabetes) – Pipeline by Astellas Pharma Inc,

Table 47: Type1 diabetes (Juvenile Diabetes) – Pipeline by AstraZeneca Plc,

Table 48: Type1 diabetes (Juvenile Diabetes) – Pipeline by Atlantic Bio Sci LLC,

Table 49: Type1 diabetes (Juvenile Diabetes) – Pipeline by Axxam SpA,

Table 50: Type1 diabetes (Juvenile Diabetes) – Pipeline by Beta-Cell NV,

Table 51: Type1 diabetes (Juvenile Diabetes) – Pipeline by Biocon Ltd,

Table 52: Type1 diabetes (Juvenile Diabetes) – Pipeline by BioLineRx Ltd,

Table 53: Type1 diabetes (Juvenile Diabetes) – Pipeline by BioLingus AG,

Table 54: Type1 diabetes (Juvenile Diabetes) – Pipeline by Biozeus,

Table 55: Type1 diabetes (Juvenile Diabetes) – Pipeline by BirchBioMed Inc,

Table 56: Type1 diabetes (Juvenile Diabetes) – Pipeline by Boehringer Ingelheim GmbH,

Table 57: Type1 diabetes (Juvenile Diabetes) – Pipeline by Boston Therapeutics Inc,

Table 58: Type1 diabetes (Juvenile Diabetes) – Pipeline by BTB Pharma AB,

Table 59: Type1 diabetes (Juvenile Diabetes) – Pipeline by Caladrius Biosciences Inc,

Table 60: Type1 diabetes (Juvenile Diabetes) – Pipeline by Cancer Prevention Pharmaceuticals Inc,

Table 61: Type1 diabetes (Juvenile Diabetes) – Pipeline by Cellix Bio Pvt Ltd,

Table 62: Type1 diabetes (Juvenile Diabetes) – Pipeline by Compugen Ltd,

Table 63: Type1 diabetes (Juvenile Diabetes) – Pipeline by Daewoong Pharmaceutical Co Ltd,

Table 64: Type1 diabetes (Juvenile Diabetes) – Pipeline by Dance Biopharm Inc,

Table 65: Type1 diabetes (Juvenile Diabetes) – Pipeline by DanDrit Biotech A/S,

Table 66: Type1 diabetes (Juvenile Diabetes) – Pipeline by Denceptor Therapeutics Ltd,

Table 67: Type1 diabetes (Juvenile Diabetes) – Pipeline by Diabetology (Products) Ltd,

Table 68: Type1 diabetes (Juvenile Diabetes) – Pipeline by Diamyd Medical AB,

Table 69: Type1 diabetes (Juvenile Diabetes) – Pipeline by Diasome Pharmaceuticals Inc,

Table 70: Type1 diabetes (Juvenile Diabetes) – Pipeline by DiaVacs Inc,

Table 71: Type1 diabetes (Juvenile Diabetes) – Pipeline by Dompe Farmaceutici SpA,

Table 72: Type1 diabetes (Juvenile Diabetes) – Pipeline by Eli Lilly and Co,

Table 73: Type1 diabetes (Juvenile Diabetes) – Pipeline by Eloxx Pharmaceuticals Inc,

Table 74: Type1 diabetes (Juvenile Diabetes) – Pipeline by Ensol Biosciences Inc,

Table 75: Type1 diabetes (Juvenile Diabetes) – Pipeline by EpiVax Inc,

Table 76: Type1 diabetes (Juvenile Diabetes) – Pipeline by Evotec AG,

Table 77: Type1 diabetes (Juvenile Diabetes) – Pipeline by Fate Therapeutics Inc,

Table 78: Type1 diabetes (Juvenile Diabetes) – Pipeline by Generex Biotechnology Corp,

Table 79: Type1 diabetes (Juvenile Diabetes) – Pipeline by GeNeuro SA,

Table 80: Type1 diabetes (Juvenile Diabetes) – Pipeline by Geropharm LLC,

Table 81: Type1 diabetes (Juvenile Diabetes) – Pipeline by GlaxoSmithKline Plc,

Table 82: Type1 diabetes (Juvenile Diabetes) – Pipeline by Hanmi Pharmaceuticals Co Ltd,

Table 83: Type1 diabetes (Juvenile Diabetes) – Pipeline by ImCyse SA,

Table 84: Type1 diabetes (Juvenile Diabetes) – Pipeline by Intrexon Corp,

Table 85: Type1 diabetes (Juvenile Diabetes) – Pipeline by Johnson & Johnson,

Table 86: Type1 diabetes (Juvenile Diabetes) – Pipeline by Just Biotherapeutics Inc,

Table 87: Type1 diabetes (Juvenile Diabetes) – Pipeline by Kadimastem Ltd,

Table 88: Type1 diabetes (Juvenile Diabetes) – Pipeline by Kamada Ltd,

Table 89: Type1 diabetes (Juvenile Diabetes) – Pipeline by Kasiak Research Pvt Ltd,

Table 90: Type1 diabetes (Juvenile Diabetes) – Pipeline by Lexicon Pharmaceuticals Inc,

Table 91: Type1 diabetes (Juvenile Diabetes) – Pipeline by MannKind Corp,

Table 92: Type1 diabetes (Juvenile Diabetes) – Pipeline by Maruho Co Ltd,

Table 93: Type1 diabetes (Juvenile Diabetes) – Pipeline by MedImmune LLC,

Table 94: Type1 diabetes (Juvenile Diabetes) – Pipeline by Medtronic Plc,

Table 95: Type1 diabetes (Juvenile Diabetes) – Pipeline by Medy-Tox Inc,

Table 96: Type1 diabetes (Juvenile Diabetes) – Pipeline by Merck & Co Inc,

Table 97: Type1 diabetes (Juvenile Diabetes) – Pipeline by Meridigen Biotech Co Ltd,

Table 98: Type1 diabetes (Juvenile Diabetes) – Pipeline by Neovacs SA,

Table 99: Type1 diabetes (Juvenile Diabetes) – Pipeline by Novo Nordisk AS,

Table 100: Type1 diabetes (Juvenile Diabetes) – Pipeline by Oramed Pharmaceuticals Inc,

Table 101: Type1 diabetes (Juvenile Diabetes) – Pipeline by Orgenesis Inc,

Table 102: Type1 diabetes (Juvenile Diabetes) – Pipeline by OSE Immunotherapeutics,

Table 103: Type1 diabetes (Juvenile Diabetes) – Pipeline by Paras Biopharmaceuticals Finland Oy,

Table 104: Type1 diabetes (Juvenile Diabetes) – Pipeline by Parvus Therapeutics Inc,

Table 105: Type1 diabetes (Juvenile Diabetes) – Pipeline by Pathfinder Cell Therapy Inc,

Table 106: Type1 diabetes (Juvenile Diabetes) – Pipeline by Pfizer Inc,

Table 107: Type1 diabetes (Juvenile Diabetes) – Pipeline by PharmaCyte Biotech Inc,

Table 108: Type1 diabetes (Juvenile Diabetes) – Pipeline by PharmaIN Corp,

Table 109: Type1 diabetes (Juvenile Diabetes) – Pipeline by Pharmasum Therapeutics AS,

Table 110: Type1 diabetes (Juvenile Diabetes) – Pipeline by Prometheon Pharma LLC,

Table 111: Type1 diabetes (Juvenile Diabetes) – Pipeline by Purzer Pharmaceutical Co Ltd,

Table 112: Type1 diabetes (Juvenile Diabetes) – Pipeline by RedHill Biopharma Ltd,

Table 113: Type1 diabetes (Juvenile Diabetes) – Pipeline by REGiMMUNE Corp,

Table 114: Type1 diabetes (Juvenile Diabetes) – Pipeline by Reliance Life Sciences Pvt Ltd,

Table 115: Type1 diabetes (Juvenile Diabetes) – Pipeline by reMYND NV,

Table 116: Type1 diabetes (Juvenile Diabetes) – Pipeline by Renova Therapeutics Inc,

Table 117: Type1 diabetes (Juvenile Diabetes) – Pipeline by Rezolute Inc,

Table 118: Type1 diabetes (Juvenile Diabetes) – Pipeline by Rubius Therapeutics Inc,

Table 119: Type1 diabetes (Juvenile Diabetes) – Pipeline by Sanofi,

Table 120: Type1 diabetes (Juvenile Diabetes) – Pipeline by Semma Therapeutics Inc,

Table 121: Type1 diabetes (Juvenile Diabetes) – Pipeline by Sotio AS,

Table 122: Type1 diabetes (Juvenile Diabetes) – Pipeline by Tetragenetics Inc,

Table 123: Type1 diabetes (Juvenile Diabetes) – Pipeline by Thermalin Diabetes LLC,

Table 124: Type1 diabetes (Juvenile Diabetes) – Pipeline by Toleranzia AB,

Table 125: Type1 diabetes (Juvenile Diabetes) – Pipeline by Tolerion Inc,

Table 126: Type1 diabetes (Juvenile Diabetes) – Pipeline by Topas Therapeutics GmbH,

Table 127: Type1 diabetes (Juvenile Diabetes) – Pipeline by Transgene Biotek Ltd,

Table 128: Type1 diabetes (Juvenile Diabetes) – Pipeline by UCB SA,

Table 129: Type1 diabetes (Juvenile Diabetes) – Pipeline by Unicyte AG,

Table 130: Type1 diabetes (Juvenile Diabetes) – Pipeline by Ventria Bioscience,

Table 131: Type1 diabetes (Juvenile Diabetes) – Pipeline by ViaCyte Inc,

Table 132: Type1 diabetes (Juvenile Diabetes) – Pipeline by vTv Therapeutics Inc,

Table 133: Type1 diabetes (Juvenile Diabetes) – Pipeline by XERIS Pharmaceuticals Inc,

Table 134: Type1 diabetes (Juvenile Diabetes) – Pipeline by XL-protein GmbH,

Table 135: Type1 diabetes (Juvenile Diabetes) – Pipeline by Zealand Pharma AS,

Table 136: Type2 diabetes – Pipeline by Adocia SAS,

Table 137: Type2 diabetes – Pipeline by Aegis Therapeutics LLC,

Table 138: Type2 diabetes – Pipeline by AFFiRiS AG,

Table 139: Type2 diabetes – Pipeline by Akcea Therapeutics Inc,

Table 140: Type2 diabetes – Pipeline by Allist Shanghai Pharmaceutical Technology Co Ltd,

Table 141: Type2 diabetes – Pipeline by Amarantus Bioscience Holdings Inc,

Table 142: Type2 diabetes – Pipeline by Amgen Inc,

Table 143: Type2 diabetes – Pipeline by Aphios Corp,

Table 144: Type2 diabetes – Pipeline by Arecor Ltd,

Table 145: Type2 diabetes – Pipeline by Arena Pharmaceuticals Inc,

Table 146: Type2 diabetes – Pipeline by AstraZeneca Plc,

Table 147: Type2 diabetes – Pipeline by AusBio Ltd,

Table 148: Type2 diabetes – Pipeline by Avadel Pharmaceuticals Plc,

Table 149: Type2 diabetes – Pipeline by Bayer AG,

Table 150: Type2 diabetes – Pipeline by Betagenon AB,

Table 151: Type2 diabetes – Pipeline by Betta Pharmaceuticals Co Ltd,

Table 152: Type2 diabetes – Pipeline by Biocon Ltd,

Table 153: Type2 diabetes – Pipeline by BioLingus AG,

Table 154: Type2 diabetes – Pipeline by BioRestorative Therapies Inc,

Table 155: Type2 diabetes – Pipeline by Biozeus,

Table 156: Type2 diabetes – Pipeline by Biscayne Pharmaceuticals Inc,

Table 157: Type2 diabetes – Pipeline by Boehringer Ingelheim GmbH,

Table 158: Type2 diabetes – Pipeline by Boston Therapeutics Inc,

Table 159: Type2 diabetes – Pipeline by Braasch Biotech LLC,

Table 160: Type2 diabetes – Pipeline by Bristol-Myers Squibb Co,

Table 161: Type2 diabetes – Pipeline by C4X Discovery Holdings PLC,

Table 162: Type2 diabetes – Pipeline by Cadila Healthcare Ltd,

Table 163: Type2 diabetes – Pipeline by Cadila Pharmaceuticals Ltd,

Table 164: Type2 diabetes – Pipeline by Caelus Health,

Table 165: Type2 diabetes – Pipeline by Cardax Inc,

Table 166: Type2 diabetes – Pipeline by Carmot Therapeutics Inc,

Table 167: Type2 diabetes – Pipeline by Cellix Bio Pvt Ltd,

Table 168: Type2 diabetes – Pipeline by Celon Pharma SA,

Table 169: Type2 diabetes – Pipeline by Center Laboratories Inc,

Table 170: Type2 diabetes – Pipeline by Chipscreen Biosciences Ltd,

Table 171: Type2 diabetes – Pipeline by Chong Kun Dang Pharmaceutical Corp,

Table 172: Type2 diabetes – Pipeline by Cinnagen Co,

Table 173: Type2 diabetes – Pipeline by CJ HealthCare Corp,

Table 174: Type2 diabetes – Pipeline by CohBar Inc,

Table 175: Type2 diabetes – Pipeline by Concenter BioPharma Silkim Ltd,

Table 176: Type2 diabetes – Pipeline by CymaBay Therapeutics Inc,

Table 177: Type2 diabetes – Pipeline by Daewoong Pharmaceutical Co Ltd,

Table 178: Type2 diabetes – Pipeline by Daiichi Sankyo Co Ltd,

Table 179: Type2 diabetes – Pipeline by Dance Biopharm Inc,

Table 180: Type2 diabetes – Pipeline by Delpor Inc,

Table 181: Type2 diabetes – Pipeline by Diabetology (Products) Ltd,

Table 182: Type2 diabetes – Pipeline by Diamyd Medical AB,

Table 183: Type2 diabetes – Pipeline by Diasome Pharmaceuticals Inc,

Table 184: Type2 diabetes – Pipeline by DiscoveryBiomed Inc,

Table 185: Type2 diabetes – Pipeline by DNJ Pharma Inc,

Table 186: Type2 diabetes – Pipeline by Dong-A Socio Holdings Co Ltd,

Table 187: Type2 diabetes – Pipeline by Elcelyx Therapeutics Inc,

Table 188: Type2 diabetes – Pipeline by Eli Lilly and Co,

Table 189: Type2 diabetes – Pipeline by Eloxx Pharmaceuticals Inc,

Table 190: Type2 diabetes – Pipeline by Energenesis Biomedical Co Ltd,

Table 191: Type2 diabetes – Pipeline by Enteris BioPharma Inc,

Table 192: Type2 diabetes – Pipeline by Enzene Biosciences Ltd,

Table 193: Type2 diabetes – Pipeline by Enzo Biochem Inc,

Table 194: Type2 diabetes – Pipeline by Epichem Pty Ltd,

Table 195: Type2 diabetes – Pipeline by Eternygen GmbH,

Table 196: Type2 diabetes – Pipeline by Evotec AG,

Table 197: Type2 diabetes – Pipeline by F. Hoffmann-La Roche Ltd,

Table 198: Type2 diabetes – Pipeline by Generex Biotechnology Corp,

Table 199: Type2 diabetes – Pipeline by Genexine Inc,

Table 200: Type2 diabetes – Pipeline by Genfit SA,

Table 201: Type2 diabetes – Pipeline by Genmedica Therapeutics SL,

Table 202: Type2 diabetes – Pipeline by Genovate Biotechnology Co LTD,

Table 203: Type2 diabetes – Pipeline by Geropharm LLC,

Table 204: Type2 diabetes – Pipeline by Gilead Sciences Inc,

Table 205: Type2 diabetes – Pipeline by GlaxoSmithKline Plc,

Table 206: Type2 diabetes – Pipeline by Glucox Biotech AB,

Table 207: Type2 diabetes – Pipeline by Hanmi Pharmaceuticals Co Ltd,

Table 208: Type2 diabetes – Pipeline by Heptares Therapeutics Ltd,

Table 209: Type2 diabetes – Pipeline by HitGen LTD,

Table 210: Type2 diabetes – Pipeline by Hyundai Pharmaceutical Co Ltd,

Table 211: Type2 diabetes – Pipeline by Immupharma Plc,

Table 212: Type2 diabetes – Pipeline by Immuron Ltd,

Table 213: Type2 diabetes – Pipeline by Inflazome Ltd,

Table 214: Type2 diabetes – Pipeline by Innovative Targeting Solutions Inc,

Table 215: Type2 diabetes – Pipeline by Inspyr Therapeutics Inc,

Table 216: Type2 diabetes – Pipeline by InStar Technologies AS,

Table 217: Type2 diabetes – Pipeline by Intarcia Therapeutics Inc,

Table 218: Type2 diabetes – Pipeline by Intas Pharmaceuticals Ltd,

Table 219: Type2 diabetes – Pipeline by Integral Molecular Inc,

Table 220: Type2 diabetes – Pipeline by Intercept Pharmaceuticals Inc,

Table 221: Type2 diabetes – Pipeline by Intrexon Corp,

Table 222: Type2 diabetes – Pipeline by Ionis Pharmaceuticals Inc,

Table 223: Type2 diabetes – Pipeline by Japan Tobacco Inc,

Table 224: Type2 diabetes – Pipeline by Jeil Pharmaceutical Co Ltd,

Table 225: Type2 diabetes – Pipeline by JHL Biotech Inc,

Table 226: Type2 diabetes – Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd,

Table 227: Type2 diabetes – Pipeline by Jiangsu Hengrui Medicine Co Ltd,

Table 228: Type2 diabetes – Pipeline by Johnson & Johnson,

Table 229: Type2 diabetes – Pipeline by Kadimastem Ltd,

Table 230: Type2 diabetes – Pipeline by Kadmon Corp LLC,

Table 231: Type2 diabetes – Pipeline by Kissei Pharmaceutical Co Ltd,

Table 232: Type2 diabetes – Pipeline by Kowa Co Ltd,

Table 233: Type2 diabetes – Pipeline by Laboratorios Silanes SA de CV,

Table 234: Type2 diabetes – Pipeline by Lead Discovery Center GmbH,

Table 235: Type2 diabetes – Pipeline by Leading BioSciences Inc,

Table 236: Type2 diabetes – Pipeline by Lexicon Pharmaceuticals Inc,

Table 237: Type2 diabetes – Pipeline by LG Chem Ltd,

Table 238: Type2 diabetes – Pipeline by LipimetiX Development Inc,

Table 239: Type2 diabetes – Pipeline by Longevity Biotech Inc,

Table 240: Type2 diabetes – Pipeline by Luye Pharma Group Ltd,

Table 241: Type2 diabetes – Pipeline by Magnus Life Ltd,

Table 242: Type2 diabetes – Pipeline by MannKind Corp,

Table 243: Type2 diabetes – Pipeline by Medesis Pharma SA,

Table 244: Type2 diabetes – Pipeline by MedImmune LLC,

Table 245: Type2 diabetes – Pipeline by Medlab Clinical Ltd,

Table 246: Type2 diabetes – Pipeline by Merck & Co Inc,

Table 247: Type2 diabetes – Pipeline by Mesoblast Ltd,

Table 248: Type2 diabetes – Pipeline by Metabolic Solutions Development Company LLC,

Table 249: Type2 diabetes – Pipeline by Metabolys SAS,

Table 250: Type2 diabetes – Pipeline by Metacrine Inc,

Table 251: Type2 diabetes – Pipeline by Mitsubishi Chemical Holdings Corp,

Table 252: Type2 diabetes – Pipeline by Mitsubishi Tanabe Pharma Corp,

Table 253: Type2 diabetes – Pipeline by Naia Ltd,

Table 254: Type2 diabetes – Pipeline by Neurimmune Holding AG,

Table 255: Type2 diabetes – Pipeline by NGM Biopharmaceuticals Inc,

Table 256: Type2 diabetes – Pipeline by Novapeutics LLC,

Table 257: Type2 diabetes – Pipeline by Novartis AG,

Table 258: Type2 diabetes – Pipeline by NovaTarg Therapeutics Inc,

Table 259: Type2 diabetes – Pipeline by Novo Nordisk AS,

Table 260: Type2 diabetes – Pipeline by Omeros Corp,

Table 261: Type2 diabetes – Pipeline by OPKO Biologics Ltd,

Table 262: Type2 diabetes – Pipeline by OPKO Health Inc,

Table 263: Type2 diabetes – Pipeline by Oramed Pharmaceuticals Inc,

Table 264: Type2 diabetes – Pipeline by Original BioMedicals Co Ltd,

Table 265: Type2 diabetes – Pipeline by Palatin Technologies Inc,

Table 266: Type2 diabetes – Pipeline by Panacea Biotec Ltd,

Table 267: Type2 diabetes – Pipeline by Paras Biopharmaceuticals Finland Oy,

Table 268: Type2 diabetes – Pipeline by Peptron Inc,

Table 269: Type2 diabetes – Pipeline by Pfizer Inc,

Table 270: Type2 diabetes – Pipeline by PharmaCyte Biotech Inc,

Table 271: Type2 diabetes – Pipeline by PharmaIN Corp,

Table 272: Type2 diabetes – Pipeline by Pila Pharma AB,

Table 273: Type2 diabetes – Pipeline by Poxel SA,

Table 274: Type2 diabetes – Pipeline by Prometheon Pharma LLC,

Table 275: Type2 diabetes – Pipeline by ProMetic Life Sciences Inc,

Table 276: Type2 diabetes – Pipeline by Prothena Corp Plc,

Table 277: Type2 diabetes – Pipeline by Purzer Pharmaceutical Co Ltd,

Table 278: Type2 diabetes – Pipeline by Reata Pharmaceuticals Inc,

Table 279: Type2 diabetes – Pipeline by reMYND NV,

Table 280: Type2 diabetes – Pipeline by Renova Therapeutics Inc,

Table 281: Type2 diabetes – Pipeline by Reset Therapeutics Inc,

Table 282: Type2 diabetes – Pipeline by Rezolute Inc,

Table 283: Type2 diabetes – Pipeline by Saniona AB,

Table 284: Type2 diabetes – Pipeline by Sanofi,

Table 285: Type2 diabetes – Pipeline by Sanwa Kagaku Kenkyusho Co Ltd,

Table 286: Type2 diabetes – Pipeline by SATT Conectus Alsace SAS,

Table 287: Type2 diabetes – Pipeline by SBI Pharmaceuticals Co Ltd,

Table 288: Type2 diabetes – Pipeline by ScandiCure AB,

Table 289: Type2 diabetes – Pipeline by Seres Therapeutics Inc,

Table 290: Type2 diabetes – Pipeline by Serodus ASA,

Table 291: Type2 diabetes – Pipeline by Serometrix LLC,

Table 292: Type2 diabetes – Pipeline by Shenzhen HighTide Biopharmaceutical Ltd,

Table 293: Type2 diabetes – Pipeline by Shionogi & Co Ltd,

Table 294: Type2 diabetes – Pipeline by Sirona Biochem Corp,

Table 295: Type2 diabetes – Pipeline by SJT Molecular Research SL,

Table 296: Type2 diabetes – Pipeline by SK Chemicals Co Ltd,

Table 297: Type2 diabetes – Pipeline by Sprint Bioscience AB,

Table 298: Type2 diabetes – Pipeline by Sumitomo Dainippon Pharma Co Ltd,

Table 299: Type2 diabetes – Pipeline by Suzuken Co Ltd,

Table 300: Type2 diabetes – Pipeline by Taisho Pharmaceutical Holdings Co Ltd,

Table 301: Type2 diabetes – Pipeline by Takeda Pharmaceutical Co Ltd,

Table 302: Type2 diabetes – Pipeline by Teijin Pharma Ltd,

Table 303: Type2 diabetes – Pipeline by The Medicines Company,

Table 304: Type2 diabetes – Pipeline by Theracos Inc,

Table 305: Type2 diabetes – Pipeline by Thermalin Diabetes LLC,

Table 306: Type2 diabetes – Pipeline by Tiziana Life Sciences Plc,

Table 307: Type2 diabetes – Pipeline by Toray Industries Inc,

Table 308: Type2 diabetes – Pipeline by Torrent Pharmaceuticals Ltd,

Table 309: Type2 diabetes – Pipeline by Transgene Biotek Ltd,

Table 310: Type2 diabetes – Pipeline by TTY Biopharm Company Ltd,

Table 311: Type2 diabetes – Pipeline by Twoxar Inc,

Table 312: Type2 diabetes – Pipeline by Uni-Bio Science Group Ltd,

Table 313: Type2 diabetes – Pipeline by ViaCyte Inc,

Table 314: Type2 diabetes – Pipeline by Vichem Chemie Research Ltd,

Table 315: Type2 diabetes – Pipeline by Vicore Pharma AB,

Table 316: Type2 diabetes – Pipeline by Viking Therapeutics Inc,

Table 317: Type2 diabetes – Pipeline by Vivus Inc,

Table 318: Type2 diabetes – Pipeline by vTv Therapeutics Inc,

Table 319: Type2 diabetes – Pipeline by Vybion Inc,

Table 320: Type2 diabetes – Pipeline by XBiotech Inc,

Table 321: Type2 diabetes – Pipeline by XERIS Pharmaceuticals Inc,

Table 322: Type2 diabetes – Pipeline by XL-protein GmbH,

Table 323: Type2 diabetes – Pipeline by XOMA Corp,

Table 324: Type2 diabetes – Pipeline by XuanZhu Pharma Co Ltd,

Table 325: Type2 diabetes – Pipeline by Yabao Pharmaceutical Group Co Ltd,

Table 326: Type2 diabetes – Pipeline by Yuhan Corp,

Table 327: Type2 diabetes – Pipeline by Zafgen Inc,

Table 328: Type2 diabetes – Pipeline by Zealand Pharma AS,

Table 329: Hyperinsulinemia – Pipeline by Crinetics Pharmaceuticals Inc,

Table 330: Hyperinsulinemia – Pipeline by Eiger BioPharmaceuticals Inc,

Table 331: Hyperinsulinemia – Pipeline by Hanmi Pharmaceuticals Co Ltd,

Table 332: Hyperinsulinemia – Pipeline by Heptares Therapeutics Ltd,

Table 333: Hyperinsulinemia – Pipeline by Rezolute Inc,

Table 334: Hyperinsulinemia – Pipeline by Zealand Pharma AS,

Table 335: Hyperglycemia – Pipeline by FGH BioTech Inc,

Table 336: Type1 diabetes (Juvenile Diabetes) – Dormant Projects,

Table 337: Type2 diabetes – Dormant Projects,

Table 338: Hyperinsulinemia – Dormant Projects,

Table 339: Hyperglycemia – Dormant Projects,

Table 340: Type1 diabetes (Juvenile Diabetes) – Discontinued Products,

Table 341: Type2 diabetes – Discontinued Products,

Table 342: Hyperglycemia – Discontinued Products,

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards